Menu

  • Lung Health & Thoracic Surgery
  • Reimbursement
  • Medtronic Academy

    • Too many lung cancer cases are diagnosed late-stage1— or not at all.

    But we believe that can change.

    Through partnership and a shared vision, we can use advanced diagnostics and minimally invasive surgical solutions to turn lung cancer into a more manageable and treatable disease.2–4

     

    United to improve lung health care and patient outcomes

    As early identification of patients increases through expanded screening eligibility, and nodule identification, we envision a future when lung cancer in most patients is found at an early stage.

    We are your partner for proven solutions with clinical, economical, and operational advantages — supporting the biopsy stage and providing tools for minimally invasive thoracic surgery.

    See a colorful illustration of the lungs.

    Lung health and thoracic surgery product portfolio

    Our goal is always the same: to get patients back to doing what they love — as quickly and safely as possible. We’re committed to innovating technology that optimizes outcomes for patients with lung cancer, esophageal cancer, and other diseases of the chest.

    Explore our full product portfolio

    ILLUMISITE™ fluoroscopic navigation platform

    The ILLUMISITE™ platform is designed to correct for CT-to-body divergence — the discrepancy between a static CT scan and the breathing lung — with real-time visualization that enhances image clarity, and adjusts to a dynamic environment.†,5-7

    LigaSure™ Maryland jaw thoracic sealer/divider

    The LigaSure™ Maryland jaw thoracic device is the first minimally invasive LigaSure™ device indicated for sealing, pulmonary veins and arteries up to, and including, 7 mm.‡ 8

    Signia™ stapling system
     

    The Signia™ powered stapler adjusts firing speed based on force feedback during clamp and firing to optimize stapling formation and deliver consistent staple lines. §,9,10 

    Lung cancer patient information

    Download an informational guide to help patients understand the diagnosis, staging, and surgical treatment options for lung cancer.

    View brochure (open in new window)
    Happy pickleball competitors take a water break in between sets, brandcentralphotos September22

     

     

    Lung cancer is complicated and costly — for patients, clinicians, and healthcare systems.

    We share your mission to cut through the complexity, improve patient outcomes, and reduce the cost of care. Our thoracic surgery solutions are built upon:

    • Clinical evidence: We have proven solutions that help provide a better patient experience.
    • Operational efficiencies: We offer products engineered to meet your needs and provide support to take you to new heights.
    See a group of doctors meeting and taking notes.

        

    Products

    Filter by

    † Based on evidence from a single-center prospective study including a total of 82 consecutive patients.

    ‡ As of March 23, 2018, based on indications for use for laparoscopic LigaSure™ devices

    § Preclinical results may not correlate with clinical performance in humans.

    1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17. Erratum in: CA Cancer J Clin. 2024 Mar-Apr;74(2):203. doi: 10.3322/caac.21830. PMID: 38230766.
    2. Gildea TR, DaCosta Byfield S, Hogarth DK, Wilson DS, Quinn CC. A retrospective analysis of delays in the diagnosis of lung cancer and associated costs. Clinicoecon Outcomes Res. 2017;9:261–269.
    3. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355(17):1763–1771.
    4. LeMense GP, Waller EA, Campbell C, Bowen T. Development and outcomes of a comprehensive multidisciplinary incidental lung nodule and lung cancer screening program. BMC Pulm Med. 2020;20(1):115. doi:10.1186/s12890-020-1129-7.
    5. Pritchett MA, Bhadra K, Calcutt M, Folch E. Virtual or reality: divergence between preprocedural computed tomography scans and lung anatomy during guided bronchoscopy. J Thorac Dis 2020;12(4):1595–1611.
    6. Pritchett MA, Bhadra K, Mattingley JS. Electromagnetic navigation bronchoscopy with tomosynthesis-based visualization and positional correction: three-dimensional accuracy as confirmed by cone-beam computed tomography. J Bronchology Interv Pulmonol. 2021; 28(1):10–20. 
    7. Avasarala SK, Roller L, Katsis J, et al. Sight unseen: diagnostic yield and safety outcomes of a novel multimodality navigation bronchoscopy platform with real-time target acquisition. Respiration. 2022;101(2):166–173. doi: 10.1159/000518009.
    8. Internal report RE00147462 Pulmonary sealing claims for the LigaSure(TM) Maryland jaw thoracic LF1930T device (memo). March 28, 2018.
    9. Based on internal test report R2146-173-0, ASA verification testing with slow speed force limit evaluation. 2015.
    10. Based on internal test report R2146-151-0, Powered stapling firing speed DOE analysis and ASA parameters. 2015.